10 Strong Buy Signals for September 2026: TSM Leads with 78 Score

September 2026: Top 10 Stocks Flashing Strong Signals and High Confidence

As September 2026 unfolds, MarketsHost.com's OpportunityRadar scanner has identified a compelling set of equity signals, with Taiwan Semiconductor Manufacturing (TSM) leading the pack with an impressive OpportunityRadar Score of 78. This top-tier score is underpinned by a robust fundamental rating of 95, signaling a strong underlying profile even as many specific fundamental metrics are noted as N/A in today's scan. Alongside TSM, several other companies, including GitLab Inc. (GTLB), Opko Health, Inc. (OPK), ScanSource, Inc. (SCSC), and Excelerate Energy, Inc. (EE), are flashing 100% confidence on their respective buy signals, indicating a high degree of alignment across multiple analytical factors.

Today's scan highlights a dynamic market landscape, with 4 of the top 10 profiled tickers registering a 100% confidence rating on their buy signals. The average OpportunityRadar Score across these initial ten selections stands at 66.6, with an average confidence level of 90.8%. Technical indicators show a split, with 5 of these tickers displaying a MACD BULL signal, while the remaining 5 indicate a MACD BEAR trend, suggesting a nuanced technical picture that warrants closer examination alongside the strong buy signals. Amylyx Pharmaceuticals, Inc. (AMLX) demonstrated particularly strong recent performance, with a 1-month return of 40.33% and a 3-month return of 146.36%.

Top 10 Signals at a Glance

#1: TSM — Taiwan Semiconductor Manufactu

Taiwan Semiconductor Manufacturing (TSM) registers the highest OpportunityRadar Score in today's scan at 78, reflecting a strong overall outlook. The company's fundamental score is particularly robust at 95, significantly outweighing its technical score of 67. The scanner indicates a 'BUY' signal with an 83% confidence level and a 'STRONG ENTRY' recommendation. TSM's current price stands at $435.63. Technical indicators show an RSI of 59.3, placing it in a healthy, non-overbought zone, and the MACD is signaling a BULL trend. Over the past month, TSM has delivered a 3.22% return, extending to 6.58% over three months. The Risk/Reward ratio is noted at 2.0, suggesting a favorable balance between potential gains and losses. It is important to note that specific fundamental metrics such as P/E, EPS, D/E, and earnings/revenue growth are marked as N/A in the current scanner data, as are detailed technical components like ADX, Stochastics, Bollinger Bands, and specific price targets or support/resistance levels.

A point to consider for TSM is the absence of detailed fundamental data in the current scan, with P/E, EPS, D/E, and growth metrics all marked as N/A. While the fundamental score of 95 is very high, the lack of specific numerical transparency for these core financial health indicators means that the underlying drivers of this fundamental strength are not immediately visible from the provided data. Investors would need to seek external information to understand the specific financial performance metrics supporting the high fundamental score.

#2: GTLB — GitLab Inc.

GitLab Inc. (GTLB) presents a 'STRONG BUY' signal with a perfect 100% confidence rating, indicating a high degree of conviction from the OpportunityRadar system. The stock is currently priced at $46.76 and is flagged for a 'STRONG ENTRY'. Its overall OpportunityRadar Score is 68, driven by a technical score of 76, which is notably higher than its fundamental score of 56. The RSI for GTLB is at 61.9, suggesting positive momentum without being in an overextended range, and the MACD is firmly in BULL territory. Performance-wise, GTLB has seen significant appreciation, with a 1-month return of 11.04% and an impressive 3-month return of 64.01%. The Risk/Reward ratio is 1.9, which is a moderately positive indicator for potential returns relative to risk. Similar to other entries, detailed fundamental metrics and advanced technical indicators like ADX, Stochastics, and Bollinger Bands are not available in this scan.

Despite the 'STRONG BUY' signal and 100% confidence, the fundamental score for GTLB stands at 56, which is considerably lower than its technical score of 76. This divergence suggests that while the stock's price action and technicals are very strong, the underlying fundamental picture, as assessed by the scanner, is less robust. The absence of specific fundamental metrics (P/E, EPS, D/E, growth rates) prevents a deeper understanding of this lower fundamental rating and highlights a potential area for further research beyond the scanner data.

#3: OPK — Opko Health, Inc.

Opko Health, Inc. (OPK) also stands out with a 'STRONG BUY' signal and a 100% confidence rating, positioning it as a high-conviction opportunity according to the scanner. Trading at $1.57, the stock is identified as a 'STRONG ENTRY'. OPK's OpportunityRadar Score is 67, with a strong technical component of 78, while its fundamental score is 50. The technical health is supported by an RSI of 58.4 and a MACD in BULL territory, indicating positive price momentum. In terms of recent performance, OPK has delivered a 1-month return of 12.95% and a 3-month return of 9.03%. However, the Risk/Reward ratio is 1.0, which suggests that the potential reward is equal to the potential risk, making it a less favorable ratio compared to some other high-confidence signals. As with other profiled tickers, specific fundamental data and detailed technical levels are not provided in this scanner output.

The Risk/Reward ratio of 1.0 for Opko Health, Inc. (OPK) is a notable risk factor. This ratio implies that for every unit of potential reward, there is an equal unit of potential risk. While the stock carries a 'STRONG BUY' signal with 100% confidence and strong technicals, this neutral Risk/Reward ratio suggests that the potential upside may be balanced by an equivalent downside, which could be a consideration for risk-aaverse investors. The low price of $1.57 also often implies higher volatility.

#4: PAYC — Paycom Software, Inc.

Paycom Software, Inc. (PAYC) is flagged with a 'STRONG BUY' signal and an 83% confidence rating, indicating a solid opportunity with a 'STRONG ENTRY' recommendation. The stock is currently trading at $216.49. PAYC holds an OpportunityRadar Score of 67, with a technical score of 75 and a fundamental score of 56. Its RSI is at 51.2, which is near the midpoint and suggests neither overbought nor oversold conditions. However, the MACD indicator is currently in BEAR territory, presenting a divergence from the overall 'STRONG BUY' signal. Despite this, PAYC has shown strong longer-term performance, with a 3-month return of 58.35%, though its 1-month return is a more modest 2.01%. The Risk/Reward ratio for PAYC is calculated at 1.7, indicating a reasonable balance. Like other entries, specific fundamental metrics and advanced technical indicators are not available.

A key risk for Paycom Software, Inc. (PAYC) is the MACD BEAR signal, which stands in contrast to its 'STRONG BUY' signal and 83% confidence. While the overall OpportunityRadar Score is 67 and the technical score is 75, a bearish MACD suggests that recent price momentum may be weakening or has recently turned negative, potentially signaling a short-term downtrend or consolidation. This divergence warrants careful monitoring, as it could indicate a lack of consistent upward pressure despite the scanner's overall positive assessment.

#5: RGEN — Repligen Corporation

Repligen Corporation (RGEN) registers an OpportunityRadar Score of 66, with a technical score of 73 and a fundamental score of 56. The scanner issues a 'BUY' signal for RGEN with an 83% confidence level and a 'STRONG ENTRY' recommendation. The stock is priced at $167.62. Technical analysis shows an RSI of 50.3, indicating a neutral momentum state. Similar to PAYC, RGEN's MACD is in BEAR territory, which could suggest recent downward pressure or a lack of strong upward momentum despite the 'BUY' signal. Performance over the past month shows a 1.73% return, while the 3-month return is a more robust 28.19%. The Risk/Reward ratio is 2.0, implying a favorable potential return relative to risk. As with all other entries, detailed fundamental metrics and specific technical levels like ADX, Stochastics, and Bollinger Bands are not provided in this scan.

The MACD BEAR signal for Repligen Corporation (RGEN) is a notable risk. Despite receiving a 'BUY' signal with 83% confidence, the bearish MACD suggests that the recent short-term price trend may be negative or losing strength. This technical divergence could indicate that while the broader outlook might be positive, the immediate price action is not confirming a strong upward trajectory, which could lead to volatility or a period of consolidation before any potential upward movement materializes. The RSI of 50.3, being very neutral, further supports the idea of a lack of strong directional momentum.

#6: OABI — OmniAb, Inc.

OmniAb, Inc. (OABI) is highlighted with an OpportunityRadar Score of 65, comprising a technical score of 73 and a fundamental score of 53. The scanner indicates a 'BUY' signal with an 83% confidence rating and a 'STRONG ENTRY' recommendation. OABI's current price is $4.01. Technical indicators show an RSI of 52.1, suggesting a neutral to slightly positive momentum. However, the MACD is in BEAR territory, which, similar to PAYC and RGEN, points to a potential technical headwind despite the overall positive signal. OABI has demonstrated strong recent price appreciation, with a 1-month return of 18.49% and an impressive 3-month return of 68.28%. The Risk/Reward ratio is 2.0, suggesting a favorable setup. As observed across the board, specific fundamental metrics and detailed technical support/resistance levels are not available from the scanner data.

A primary risk for OmniAb, Inc. (OABI) lies in its MACD BEAR signal, which contrasts with its 'BUY' signal and strong recent returns. While the stock has shown significant 1-month and 3-month gains, a bearish MACD can indicate that the upward momentum is decelerating or has recently reversed. This technical warning suggests that the rapid price appreciation might be facing resistance or that a corrective phase could be underway, despite the overall positive signal from the OpportunityRadar system. Investors should be aware of this potential technical weakness.

#7: SCSC — ScanSource, Inc.

ScanSource, Inc. (SCSC) registers an OpportunityRadar Score of 65, with a technical score of 73 and a fundamental score of 53. The scanner assigns a 'BUY' signal to SCSC with a robust 100% confidence rating and a 'STRONG ENTRY' recommendation. The stock is currently priced at $57.15. Technical analysis reveals an RSI of 55.4, indicating healthy, upward-leaning momentum without being overbought. Critically, the MACD for SCSC is in BULL territory, aligning positively with the 'BUY' signal. Over the past month, SCSC has delivered a 10.22% return, contributing to a 16.97% return over three months. The Risk/Reward ratio is 1.7, suggesting a moderately favorable balance. As with other profiled companies, the scanner data does not provide specific fundamental metrics or detailed technical levels such as ADX, Stochastics, Bollinger Bands, price targets, or support/resistance.

While ScanSource, Inc. (SCSC) boasts a 100% confidence rating and a MACD BULL signal, its fundamental score of 53 is relatively modest compared to its technical score of 73. This suggests that the scanner's strong signal is predominantly driven by technical factors rather than a robust fundamental underpinning. The absence of specific fundamental data (P/E, EPS, D/E, growth rates) prevents a detailed understanding of this lower fundamental assessment, which could be a risk for investors who prioritize a strong fundamental profile alongside technical strength.

#8: EE — Excelerate Energy, Inc.

Excelerate Energy, Inc. (EE) is featured with an OpportunityRadar Score of 64, stemming from a technical score of 69 and a fundamental score of 56. The scanner issues a 'BUY' signal with a perfect 100% confidence rating and a 'STRONG ENTRY' recommendation, highlighting strong alignment across its confirmation factors. The stock is trading at $39.31. Technical indicators show an RSI of 54.0, suggesting balanced momentum, and the MACD is in BULL territory, which supports the positive signal. EE has demonstrated solid recent performance, with a 1-month return of 11.16% and a 3-month return of 19.94%. However, the Risk/Reward ratio is notably low at 0.4. As with all other entries, specific fundamental metrics and detailed technical levels are not available in this scanner output.

The most significant risk factor for Excelerate Energy, Inc. (EE) is its exceptionally low Risk/Reward ratio of 0.4. This ratio indicates that the potential risk associated with the investment is considerably higher than its potential reward. Despite the 100% confidence 'BUY' signal and positive MACD, a Risk/Reward of 0.4 suggests that for every unit of potential gain, there are 2.5 units of potential loss. This imbalance makes EE a high-risk proposition according to this specific metric, warranting extreme caution for investors considering this signal.

#9: BLFS — BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) receives an OpportunityRadar Score of 63, with a technical score of 71 and a fundamental score of 50. The scanner indicates a 'BUY' signal with an 83% confidence rating and a 'STRONG ENTRY' recommendation. The stock is priced at $35.3. Technical analysis shows an RSI of 53.3, suggesting a neutral to slightly positive momentum. However, similar to several other tickers in this scan, the MACD for BLFS is in BEAR territory, indicating a potential weakening of recent price trends. While the 1-month return is a modest 1.38%, the 3-month return is a more robust 32.41%. The Risk/Reward ratio is 1.6, suggesting a reasonable balance between potential gains and losses. As with all other entries, specific fundamental metrics and detailed technical levels are not available in this scanner output.

A key risk for BioLife Solutions, Inc. (BLFS) is the MACD BEAR signal, which contrasts with its overall 'BUY' signal. While the stock has delivered a strong 3-month return of 32.41%, the bearish MACD suggests that the recent short-term price momentum may be negative or has recently turned unfavorable. This technical indicator divergence could imply that the stock is facing some selling pressure or entering a period of consolidation, which could challenge the immediate upside potential indicated by the 'BUY' signal.

#10: AMLX — Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. (AMLX) rounds out our top 10 with an OpportunityRadar Score of 63, comprising a technical score of 69 and a fundamental score of 53. The scanner issues a 'BUY' signal with an 83% confidence rating and a 'STRONG ENTRY' recommendation. The stock is currently trading at $33.16. Technical indicators show an RSI of 59.0, indicating healthy momentum without being overbought. However, the MACD for AMLX is in BEAR territory, which, similar to several other profiled tickers, suggests a potential technical headwind. Despite this, AMLX has demonstrated exceptional short-term performance, with a 1-month return of 40.33% and an outstanding 3-month return of 146.36%. The Risk/Reward ratio is 2.0, indicating a favorable balance. As with all other entries, specific fundamental metrics and detailed technical levels are not available in this scanner output.

Despite its impressive 1-month and 3-month returns, a significant risk for Amylyx Pharmaceuticals, Inc. (AMLX) is the MACD BEAR signal. This bearish MACD, in the context of very strong recent price performance, could indicate that the rapid upward momentum is decelerating or that the stock is becoming vulnerable to a pullback. While the 'BUY' signal with 83% confidence is positive, the MACD divergence suggests that the immediate technical picture might be less robust than the historical returns imply, warranting careful consideration of potential short-term volatility.

Key Observations Across the Scan

Analyzing the initial 10 tickers from today's OpportunityRadar scan reveals several patterns. Four of the ten profiled tickers—GitLab Inc. (GTLB), Opko Health, Inc. (OPK), ScanSource, Inc. (SCSC), and Excelerate Energy, Inc. (EE)—are flagged with a 100% confidence rating on their buy signals, indicating strong alignment across the scanner's confirmation factors. Technical alignment shows that five of these tickers (TSM, GTLB, OPK, SCSC, EE) display a MACD in BULL territory, supporting their positive signals. Conversely, the remaining five (PAYC, RGEN, OABI, BLFS, AMLX) indicate a MACD BEAR trend, which presents a nuanced technical picture. Amylyx Pharmaceuticals, Inc. (AMLX) stands out as a momentum leader, delivering a 1-month return of 40.33% and a 3-month return of 146.36%, making it the top performer by these metrics among the profiled group. OmniAb, Inc. (OABI) also shows strong recent gains with an 18.49% 1-month return and 68.28% 3-month return. The average RSI across these ten tickers is 55.49, generally suggesting healthy, non-overbought conditions, with individual readings ranging from Paycom Software, Inc.'s (PAYC) 51.2 to GitLab Inc.'s (GTLB) 61.9.

Key Risk Factors

Based on the provided scanner data for the top 10 tickers, several concrete risk factors emerge:

• Divergent MACD Signals: A notable risk factor is the presence of a MACD BEAR signal for five of the profiled tickers—Paycom Software, Inc. (PAYC), Repligen Corporation (RGEN), OmniAb, Inc. (OABI), BioLife Solutions, Inc. (BLFS), and Amylyx Pharmaceuticals, Inc. (AMLX)—despite their overall BUY or STRONG BUY signals. This divergence between a positive overall signal and a bearish MACD trend could indicate potential technical headwinds or a weakening of recent price strength, suggesting that the immediate price action may not be as robust as the overall signal implies.
• Suboptimal Risk/Reward Ratios: Two tickers, Excelerate Energy, Inc. (EE) and Opko Health, Inc. (OPK), exhibit relatively low Risk/Reward ratios of 0.4 and 1.0, respectively. A lower ratio suggests that the potential upside may not significantly outweigh the potential downside based on the scanner's calculated parameters. For EE, a ratio of 0.4 indicates a notably higher risk relative to its potential reward, making it a high-risk proposition from this perspective.
• Extensive Data Gaps: A significant limitation across all profiled tickers is the widespread "N/A" status for numerous fundamental metrics (P/E, EPS, D/E, Earn growth, Rev growth) and specific technical levels (ADX, Stoch, Bollinger, Targets, Support, Resistance, Stop, Off high). This absence of detailed fundamental and specific technical breakdown data means that a comprehensive assessment of intrinsic value or precise entry/exit points is not possible solely from the provided scanner data, requiring investors to seek additional information for a complete picture.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of September 09, 2026.